Thursday’s Daily Piece: New Glucagon Prefilled Injection Option FDA Approved

Great news! Xeris’ Pharmaceuticals prefilled glucagon injection, Gvoke, has been FDA approved for severe hypoglycemia. Patients will now have another glucagon treatment option in particular to the old school glucagon injection. Prefilled syringe option will be available within next 4 – 6 weeks followed by the autoinjector in early 2020. To learn more, please click below.

This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#glucagon #prefilled #autoinjector

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.

Leave a Reply

Your email address will not be published. Required fields are marked *